Labcorp® Plasma Detect™ now available for clinical use to assess risk of recurrence in stage III colon cancer patients FDA-authorized liquid biopsy assay PGDx elio® plasma focus™ Dx now available to support… Read More
RESEARCH TRIANGLE PARK, NC – IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced that the global independent research and analysis firm Everest… Read More
First and only approved anti-CD38 therapy in combination with 3 medications (VRd) for patients newly diagnosed multiple myeloma (NDMM) not eligible for autologous stem cell transplant (ASCT) Sarclisa® reduces the… Read More
VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to congratulate its Scientific Advisor… Read More
Approval is based on the results from the Phase 3 CCTG IND.227/KEYNOTE-483 trial KIRKLAND, QC – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced… Read More
